Milsaperidone (BYSANTI): Antipsychotic Approved by Bioequivalence
- Jason Cafer MD
- 1 day ago
- 3 min read
Milsaperidone (BYSANTI) is a second-generation antipsychotic recently approved for schizophrenia and mania as an equivalent to iloperidone (FANAPT) .


Why Bysanti exists
Year | Vanda Pharmaceuticals |
2009 | Iloperidone (FANAPT) approved |
~2027 | Fanapt patents expire → generics expected |
2026 | Milsaperidone (BYSANTI) approved |
~2044 | Bysanti patent protection expected |

Milsaperidone (BYSANTI) is an active metabolite of iloperidone (FANAPT)
but not like these:
Parent drug | Direct metabolite |
Risperidone (RISPERDAL) | Paliperidone (INVEGA) |
Venlafaxine (EFFEXOR) | Desvenlafaxine (PRISTIQ) |
Loratadine (CLARITIN) | Desloratadine (CLARINEX) |
Imipramine (TOFRANIL) | Desipramine (NORPRAMIN) |
Amitriptyline (ELAVIL) | Nortriptyline (PAMELOR) |
Codeine | Morphine |
Hydrocodone | Hydromorphone (DILAUDID) |
Oxycodone | Oxymorphone (NUMORPHAN, OPANA) |
Diazepam (VALIUM) | Temazepam (RESTORIL) |
Temazepam (RESTORIL) | Oxazepam (SERAX) |
Those metabolite drugs required independent clinical trials for approval.
Milsaperidone (BYSANTI), however, was approved without new schizophrenia or mania efficacy trials, based on pharmacokinetic bioequivalence to Iloperidone (FANAPT).
Iloperidone and milsaperidone form a reversible metabolite pair—take either and both circulate.
Although milsaperidone is classified as a new chemical entity, the body rapidly interconverts iloperidone ⇄ milsaperidone, maintaining roughly 40% iloperidone / 60% milsaperidone at steady state.

This bidirectional pharmacokinetic equilibrium between two marketed drugs represents a novel patent-extension strategy. I'm unaware of other pharmaceutical examples; the closest conceptual parallels are physiologic reversible pairs such as:
Pair | Mechanism | Timescale |
Iloperidone (FANAPT) ⇄ Milsaperidone (BYSANTI) | metabolic reduction / oxidation (non-CYP) | minutes |
CO₂ ⇄ HCO₃⁻ | carbonic anhydrase equilibrium | seconds |
Cortisol ⇄ Cortisone | 11β-HSD1 / 11β-HSD2 redox enzymes | minutes–hours |
Prednisone ⇄ Prednisolone | hepatic 11β-HSD reduction | hours |
Hydromorphone ⇄ hydromorphone-3-glucuronide | UGT reversible hydrolysis (minor) | hours |
Testosterone ⇄ Androstenedione | 17β-hydroxysteroid dehydrogenase | minutes–hours |
Retinol ⇄ retinaldehyde | alcohol / aldehyde dehydrogenases | minutes–hours |
Why we might want to prescribe FANAPT/BYSANTI
It's an ultra-strong 5-HT2A antagonist → low EPS. Actually an inverse agonist.

Reminders of why FANAPT is rarely prescribed
Iloperidone/milsaperidone for Schizophrenia
Overall symptom Improvement in Schizophrenia: effect size ↓ PANSS vs placebo
More effective than iloperidone (0.33) | Less effective than iloperidone (0.33) |
Clozapine (CLOZARIL) 0.89 Amisulpride (SOLIAN) 0.73 Thiothixene (NAVANE) 0.63 Xanomeline (COBENFY) 0.61 Olanzapine (ZYPREXA) 0.56 Perphenazine (TRILAFON) 0.56 Risperidone (RISPERDAL) 0.55 Thioridazine (MELLARIL) 0.54 Paliperidone (INVEGA) 0.49 Haloperidol (HALDOL) 0.47 Loxapine (LOXITANE) 0.45 Chlorpromazine (THORAZINE) 0.44 Molindone (MOBAN) 0.42 Quetiapine (SEROQUEL) 0.42 Aripiprazole (ABILIFY) 0.41 Ziprasidone (GEODON) 0.41 Asenapine (SAPHRIS) 0.39 Lurasidone (LATUDA) 0.36 Cariprazine (VRAYLAR) 0.34 | Lumateperone (CAPLYTA) 0.30 Brexpiprazole (REXULTI) 0.26 |
Mania titration for FDA-approved drugs
Overall symptom Improvement in Schizophrenia: effect size ↓ PANSS vs placebo
<5 days to titrate | 5 days to titrate |
Lithium (LITHOBID, ESKALITH) Valproate (DEPAKENE, DEPAKOTE) Carbamazepine (TEGRETOL, EQUETRO) Chlorpromazine (THORAZINE) Aripiprazole (ABILIFY) Asenapine (SAPHRIS) Brexpiprazole (REXULTI) Cariprazine (VRAYLAR) Olanzapine (ZYPREXA) Paliperidone (INVEGA) Quetiapine (SEROQUEL) Risperidone (RISPERDAL) Ziprasidone (GEODON) | Iloperidone (FANAPT) ⇄ Milsaperidone (BYSANTI) |
Iloperidone/milsaperidone for Mania:
Leisurely titration for an urgent indication (necessitated by alpha-1 orthostasis risk).
Titration for schizophrenia is even slower.
Day / Dose | Schizophrenia | Bipolar mania |
Day 1 | 1 mg BID | 1 mg BID |
Day 2 | 2 mg BID | 3 mg BID |
Day 3 | 4 mg BID | 6 mg BID |
Day 4 | 6 mg BID | 9 mg BID |
Day 5 | 8 mg BID | 12 mg BID |
Day 6 | 10 mg BID | titration complete |
Day 7 | 12 mg BID | — |
Target dosage | 6–12 mg BID | 12 mg BID |


My grandparents listened to this guy. I doubt that you've heard of him but he had many junk country hits.



PDF books available with CaferMed.com subscription.
Copyright 2026, CaferMed Publishing
